Pharmaceutical giant Pfizer has struck a deal to let generic drug manufacturers produce its experimental COVID-19 antiviral pill, in an effort to make treatments more accessible to lower-income countries. But as Crystal Goomansingh explains, the deal only involves about half of the world’s population.
- Pfizer begins approval process for COVID-19 antiviral pill in Canada
- Pfizer to allow other companies to make its COVID-19 pill